Strategies to overcome Low Endotoxin Recovery using the conventional LAL assay

Presented by

Dr. Ruth Daniels, Janssen & Kevin L. Williams, BIOMÉRIEUX USA, Inc.

About this talk

Title: Strategies to overcome Low Endotoxin Recovery using the conventional LAL assay Presenter: Dr. Ruth Daniels, Janssen This presentation will discuss: - Endotoxin hold time studies to identify LER - In silico assessment of interfering factors and associated LER mitigation strategies - Case study: optimization of product-specific LAL assay to overcome LER Title: : Addressing LER at the root, with ENDO-RS® sample preparation (demasking) prior to endotoxin assay of choice Presenter: Kevin L. Williams, Senior Scientist Endotoxin - BIOMÉRIEUX Scientific studies have demonstrated that biologics typically containing protein in high concentrations and non-ionic surfactants, are likely to change the aggregate state of endotoxin in such a way that it is no longer accessible for detection with Factor C-based endotoxin detection methods (LAL and rFC). The ENDO-RS® endotoxin recovery method developed by Hyglos - a bioMérieux company, is a unique toolbox of dedicated reagents for demasking (recovering) endotoxin prior to detection, also for conventional LAL. This presentation covers the mechanism of LER, regulatory requirements, work principle of ENDO-RS, the demasking services of bioMérieux, as well as method application data.

Related topics:

More from this channel

Upcoming talks (19)
On-demand talks (263)
Subscribers (25075)
BioPharma Webinars aims to keep its 30,000 readers abreast of all developments in the areas of Drug Development, Drug Delivery, Manufacturing, Quality Assurance, Outsourcing and Regulatory Affairs, with only the highest quality articles, written by the most respected authors, associated with only end-user companies. This ensures that the information will always be guaranteed to remain timely, informative and above all totally unbiased.